Steroid receptor coactivator-3 as a target for anaplastic thyroid cancer | ||
| dc.conicet.organizacion | National Institutes of Health | |
| dc.conicet.organizacion | National Institutes of Health | |
| dc.conicet.organizacion | University of Ulsan College of Medicine | |
| dc.conicet.organizacion | National Institutes of Health | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología | |
| dc.conicet.organizacion | National Institutes of Health | |
| dc.conicet.organizacion | National Institutes of Health | |
| dc.conicet.organizacion | National Institutes of Health | |
| dc.conicet.organizacion | Baylor College of Medicine | |
| dc.conicet.organizacion | Baylor College of Medicine | |
| dc.conicet.organizacion | National Institutes of Health | |
| dc.contributor.author | Lee, W. K. | |
| dc.contributor.author | Kim, Won Gu | |
| dc.contributor.author | Fozzatti, Laura | |
| dc.contributor.author | Park, Sunmi | |
| dc.contributor.author | Zhao, Li | |
| dc.contributor.author | Willingham, Mark C. | |
| dc.contributor.author | Lonard, David | |
| dc.contributor.author | OMalley, Bert W. | |
| dc.contributor.author | Cheng, Sheue-yann | |
| dc.date.issued | 2020-01 | |
| dc.description.abstract | Anaplastic thyroid carcinoma (ATC) is an aggressive malignancy without effective therapeutic options to improve survival. Steroid receptor coactivator-3 (SRC-3) is a transcriptional coactivator whose amplification and/or overexpression has been identified in many cancers. In this study, we explored the expression of SRC-3 in ATCs and the effects of a new class of SRC-3 inhibitor-2 (SI-2) in human ATC cells (THJ-11T and -16T cells) and mouse xenograft models to assess therapeutic potential of SI-2 for the treatment of ATC. SRC-3 protein abundance was significantly higher in human ATC tissue samples and ATC cells than in differentiated thyroid carcinomas or normal controls. SI-2 treatment effectively reduced the SRC-3 expression in both ATC cells and ATC xenograft tumors induced by these cells. Cancer cell survival in ATC cells and tumor growth in xenograft tumors were significantly reduced by SI-2 treatment through induction of cancer cell apoptosis and cell cycle arrest. SI-2 also reduced cancer stem-like cells as shown by an inhibition of tumorsphere formation, ALDH activity and expression of stem cell markers in ATC. These findings indicate that SRC-3 is a potential therapeutic target for treatment of ATC patients, and that SI-2 is a potent and promising candidate for a new therapeutic agent. | es |
| dc.description.fil | Fil: Lee, W. K.. National Institutes of Health; Estados Unidos | |
| dc.description.fil | Fil: Kim, Won Gu. National Institutes of Health; Estados Unidos. University of Ulsan College of Medicine; Corea del Sur | |
| dc.description.fil | Fil: Fozzatti, Laura. National Institutes of Health; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina | |
| dc.description.fil | Fil: Park, Sunmi. National Institutes of Health; Estados Unidos | |
| dc.description.fil | Fil: Zhao, Li. National Institutes of Health; Estados Unidos | |
| dc.description.fil | Fil: Willingham, Mark C.. National Institutes of Health; Estados Unidos | |
| dc.description.fil | Fil: Lonard, David. Baylor College of Medicine; Estados Unidos | |
| dc.description.fil | Fil: OMalley, Bert W.. Baylor College of Medicine; Estados Unidos | |
| dc.description.fil | Fil: Cheng, Sheue-yann. National Institutes of Health; Estados Unidos | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Lee, W. K.; Kim, Won Gu; Fozzatti, Laura; Park, Sunmi; Zhao, Li; et al.; Steroid receptor coactivator-3 as a target for anaplastic thyroid cancer; BioScientifica; Endocrine - Related Cancer; 27; 4; 1-2020; 209-220 | es |
| dc.identifier.eissn | 1479-6821 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1351-0088 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/158776 | |
| dc.journal.ciudad | Bristol | es |
| dc.journal.number | 4 | es |
| dc.journal.pagination | 209-220 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | Endocrine - Related Cancer | es |
| dc.journal.volume | 27 | es |
| dc.language.iso | eng | es |
| dc.publisher | BioScientifica | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1530/ERC-19-0482 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://erc.bioscientifica.com/view/journals/erc/27/4/ERC-19-0482.xml | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | Anaplastic Thyroid Cancer | es |
| dc.subject | Steroid receptor coactivator-3 | es |
| dc.subject | Cancer stem-like cells | es |
| dc.subject.classification | Otras Ciencias Médicas | es |
| dc.subject.classification | Otras Ciencias Médicas | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Steroid receptor coactivator-3 as a target for anaplastic thyroid cancer | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.be8b1db7-c2c5-43f2-8785-62c6d8d651e0_A.pdf
- Tamaño:
- 2.77 MB
- Formato:
- Adobe Portable Document Format